Abridge
Ambient AI that drafts clinical notes and codes from the patient conversation
Overview
Abridge is an ambient AI platform that listens to clinician-patient conversations and drafts clinical notes, nursing flowsheets and billing codes inside the health system's EHR, with every statement linked back to the recording. It is sold to US health systems by contract, with no published pricing.
Pricing
Pricing shown for reference only. These figures reflect RECATOOLS research as of 14 Oct 2026 and may be out of date or incomplete. This is not financial or purchasing advice — always confirm the current price on the provider’s official website before making any decision.
- Single sign-on
- 256-bit encryption in transit and at rest
- Data stored in US-based data centres, HIPAA compliant
- Usage analytics and reporting across the health system
Use cases
What you can produce with Abridge
- Structured, specialty-specific clinical notes drafted from the patient conversation
- Note statements linked back to the source moment in the conversation
- Draft nursing flowsheet rows from bedside conversations
- ICD-10 and HCC codes surfaced at the point of care for revenue-cycle teams
- Pre-bill review comparing coded diagnoses and DRGs with the documentation
- Chart-aware answers to clinical questions from the Abridge clinical intelligence agent
- Patient summaries and captured orders at the end of the visit
ASEAN Perspective
Abridge in Southeast Asia
Abridge is currently a US-market product with no announced APAC presence, no regional data centres, and no known partnerships with hospitals in Southeast Asia, Australia, or the broader APAC region as of mid-2026. All audio and clinical data is processed in US-based servers, creating significant data-sovereignty and patient-consent obstacles under Singapore's PDPA, Malaysia's PDPA, Thailand's PDPC Act, and Australia's Privacy Act — making enterprise adoption by ASEAN health systems legally complex without contractual data-residency guarantees. The platform's 28+ language support theoretically covers Malay, Indonesian, Thai, and Tagalog, but clinical accuracy in these languages has not been independently validated, and there is no Epic footprint in most ASEAN public health systems. ASEAN healthcare providers should treat Abridge as a future-watch product rather than a deployable solution in the near term.
Abridge is one of the most widely deployed ambient scribes in US healthcare, with more than 300 health systems by its own count, KLAS's top Ambient AI ranking in the Revenue Cycle category two years running, and a platform that now reaches nursing documentation, coding and pre-bill claim review. Linking each sentence of a note to the moment it was said is the right design for catching errors.
It is an enterprise purchase only: no published price, no route for an individual clinician, and data held in US data centres. For large US health systems it is a leading option; for anyone else, including ASEAN providers, it is not yet available to buy.
What we found
Abridge turns the conversation between a clinician and a patient into a draft clinical note, and has spent the past year widening that into what it calls a clinician intelligence platform. The company, set up in 2018 by cardiologist Shiv Rao, says more than 300 US health systems use it and that it will support over 100 million patient conversations this year; those are its own counts. Recent agreements show the scale: WashU Medicine and BJC Health bringing it to about 4,000 clinicians in September 2026, a place on the Department of Veterans Affairs enterprise ambient-AI contract later that month, and an enterprise-wide framework with the University of Texas System on 8 October.
The note-writing is now one part of a larger product. Abridge sells versions for nurses, who get draft flowsheet rows from bedside conversations, and for revenue-cycle teams, where ICD-10 and HCC codes surface during the visit and, since September 2026, a pre-bill review compares coded diagnoses against the documentation before a claim goes out. A clinical intelligence agent, launched in April and opened to every clinician at partner systems in August, answers questions using the patient chart and sources such as NEJM and JAMA. Every output links back to what was said, which is the main safeguard against an invented detail.
KLAS ranked Abridge No. 1 for Ambient AI in its Revenue Cycle category in both 2025 and 2026, based on customer interviews. The money behind it is large: a $250 million Series D in February 2025 at a reported $2.75 billion valuation, then a $300 million Series E led by Andreessen Horowitz that June at a reported $5.3 billion, and in June 2026 an undisclosed strategic investment from Eli Lilly.
The catch is access. Abridge publishes no prices and sells to health systems, not individual clinicians, and its own pages say data is kept in US-based data centres. Outside the United States it is not yet an option.
Compiled by RECATOOLS from public sources: vendor documentation and pricing, code repositories and published reporting.
Notable facts
- Abridge was born from the Pittsburgh Health Data Alliance — a three-way partnership between Carnegie Mellon University, the University of Pittsburgh, and UPMC.
- Kaiser Permanente's Abridge rollout across 40 hospitals and 600 clinics is considered the largest generative AI project in healthcare history.
- Abridge's valuation nearly doubled in just four months in 2025 — from $2.75B (February) to $5.3B (June) — on the back of a $300M Series E led by Andreessen Horowitz.
- A KUMC peer-reviewed study found Abridge reduced clinician cognitive load by 61%, and at Sutter Health 78% of clinicians reported improved work satisfaction.
Frequently asked questions
About this listing
This entry was compiled from publicly available data including Abridge's official website, press releases, documentation, and reputable third-party publications. RECATOOLS is not affiliated with Abridge unless explicitly stated.
Third-party AI tools update their pricing, features, availability, and policies frequently. Information here may be outdated by the time you read this — we make reasonable efforts to keep listings current, but cannot guarantee absolute accuracy.
For the latest details, please refer to Abridge directly →
Spotted something out of date? Suggest an update →
Related reading
Alternatives to Abridge
More in Healthcare
